MNKKQ IE00BBGT3753

Report

Delayed Nyse - 09/22 03:51:32 pm
0.19556	USD		-0.48%

09/03	Mallinckrodt Reaches Settlement Agreement With More Creditors	DJ
09/02	MALLINCKRODT : Presents Interim Results on Real World Use of Extracorporeal Photopheresis (ECP) in Heart Transplant Patients in a Late-Breaking Presentation at the 20th Congress of the European Society for Organ Transplantation (ESOT)	PU
08/31	ANI PHARMACEUTICALS : FDA Accepts Application for Cortrophin Gel Revival	DJ

Summary

Quotes 5-day view Delayed Quote.

Delayed Nyse

09/16/2021	09/17/2021	09/20/2021	09/21/2021	09/22/2021	Date
0.19815(c)	0.1935(c)	0.1933(c)	0.1965(c)	0.19556	Last
490 731	228 609	364 309	252 725	177 784	Volume
-7.79%	-2.35%	-0.10%	+1.66%	-0.48%	Change

More quotes

Estimated financial data (e) (USD)

Sales 2019	3 163 M - -
Net income 2019	-997 M - -
Net Debt 2019	4 673 M - -
P/E ratio 2019	-0,31x
Yield 2019	-

Sales 2020	2 213 M - -
Net income 2020	-945 M - -
Net Debt 2020	2 558 M - -
P/E ratio 2020	-0,03x
Yield 2020	-

Capitalization	16,6 M 16,6 M -
EV / Sales 2019	1,58x
EV / Sales 2020	1,17x
Nbr of Employees	3 086
Free-Float	83,8%

More Financials

Company

Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and...

Sector

Pharmaceuticals

Calendar

05/10

Earnings Release

More about the company

All news about MALLINCKRODT PLC

09/03	Mallinckrodt Reaches Settlement Agreement With More Creditors	DJ
09/02	MALLINCKRODT : Presents Interim Results on Real World Use of Extracorporeal Photopheresis ..	PU
08/31	ANI PHARMACEUTICALS : FDA Accepts Application for Cortrophin Gel Revival	DJ
08/13	Mallinckrodt Provides Information to the Shareholders	CI
08/05	Buxton Helmsley Sends Letter to Mallinckrodt plc	CI
08/03	MALLINCKRODT : Net Debt Leverage Q2 2021 08-03-2021	PU
08/03	MALLINCKRODT : Non-GAAP Definitions Q2 2021 08-03-2021	PU
08/03	MALLINCKRODT : Second Quarter Financial Results (Form 8-K)	PU
08/03	Mallinckrodt plc Reports Earnings Results for the Second Quarter Ended June 25, 2021	CI
08/03	TRANCHE UPDATE ON MALLINCKRODT PLC ( : MNKK.Q)'s Equity Buyback Plan announced on March 1,..	CI
08/02	Buxton Helmsley Provides Information to the Shareholders	CI
07/22	ENDO INTERNATIONAL : Drugmaker Endo settles opioid claims by Tennessee counties, cities fo..	RE
07/21	U.S. state officials urge support for landmark $26 billion opioid settlement	RE
07/21	FACTBOX-Companies pay billions of dollars over role in U.S. opioid crisis	RE
07/21	Drugmakers, pharmacies next targets for U.S. opioid settlements	RE

More news

News in other languages on MALLINCKRODT PLC

02/22	DBV TECHNOLOGIES : nouvelle directrice juridique
2020	Mallinckrodt se déclare en faillite pour régler des plaintes
2020	La Vieille Europe bouge encore
2020	EN DIRECT DES MARCHES : Airbus, Atos, Veolia / Suez / Engie, Carmat, Apple, KPN...
2020	Erste Anleihen aus Corona-Zeit kommen in Schwierigkeiten

More news

Analyst Recommendations on MALLINCKRODT PLC

2016	Pharma, biotech shares soar as Trump win calms pricing talk	RE
2016	Pharma, biotech shares soar as Trump win calms pricing talk	RE

More recommendations

Provided by Scoopnest.com

Analysis

U.S. state officials urge support for landmark $26 billion opioid settlement